Poisonous Shrooms Battle Cancer

A deadly mushroom toxin shrinks pancreatic tumors in mice.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Death cap mushroomsWIKIMEDIA COMMONS, STU PHILLIPS

The death cap mushroom looks just like the common white button mushroom, but don’t mistake one for the other in your salad. The former is true to its name: death cap mushrooms (Amanita phalloides) contain a-amanitin, one of the most deadly poisons found in nature. But now, scientists from three German research centers are using that toxin for good—combating pancreatic cancer.

Published online last week (March 27) in the Journal of the National Cancer Institute, researchers attached a-amanitin to an antibody that binds to EpCAM, a cell surface protein abundant in human cancers. In a dish, the poison-loaded antibody arrested the growth of pancreatic, colorectal, breast, and bile duct cancer cell lines. In mice transplanted with human pancreatic tumors, the treatment resulted in tumor regression ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Megan Scudellari

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development